SSY Group Limited (HKG:2005)
3.400
-0.040 (-1.16%)
Apr 3, 2025, 4:08 PM HKT
SSY Group Revenue
In the year 2024, SSY Group had annual revenue of 5.77B HKD, down -10.67%. SSY Group had revenue of 2.43B in the half year ending December 31, 2024, a decrease of -19.65%.
Revenue
5.77B
Revenue Growth
-10.67%
P/S Ratio
1.74
Revenue / Employee
946.43K
Employees
5,640
Market Cap
10.04B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.77B | -689.76M | -10.67% |
Dec 31, 2023 | 6.46B | 28.98M | 0.45% |
Dec 31, 2022 | 6.43B | 1.08B | 20.11% |
Dec 31, 2021 | 5.36B | 1.10B | 25.72% |
Dec 31, 2020 | 4.26B | -374.78M | -8.08% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
Hansoh Pharmaceutical Group Company | 13.05B |
WuXi Biologics | 19.87B |
JD Health International | 61.89B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Alibaba Health Information Technology | 31.39B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |